戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  Infectious illnesses usually precede Miller Fisher syndrome.
2 nt to the clinical pathophysiology of Miller Fisher syndrome.
3  neuromyotonia, Morvan's syndrome and Miller-Fisher syndrome.
4 0 was isolated from a patient who had Miller-Fisher syndrome.
5 potential to ameliorate the course of Miller Fisher syndrome.
6 ies in the diagnosis and causation of Miller-Fisher syndrome?
7 BS (18 demyelinating, 8 axonal, and 1 Miller Fisher syndrome), 5 had encephalitis (3 with concomitant
8  transmission occurs in some cases of Miller Fisher syndrome and Guillain-Barre syndrome.
9 ater understanding of the spectrum of Miller Fisher syndromes and to refine clinical diagnoses in pat
10      Ganglioside complexes in GBS and Miller-Fisher syndrome are frequently present and are more path
11                                       Miller Fisher syndrome-associated anti-GQ1b ganglioside antibod
12 n-Barre syndrome and its variant, the Miller Fisher syndrome, during TNFalpha antagonist therapy.
13 f clinical features is reminiscent of Miller Fisher syndrome, in which acute-phase anti-disialylated
14                                       Miller Fisher syndrome is a localized variant of Guillain-Barre
15                                       Miller-Fisher syndrome is an autoimmune neuropathy characterize
16 o facilitates differentiation between Miller-Fisher Syndrome (MFS) and BBE in cases of diagnostic dou
17  of Guillain-Barre syndrome (GBS) and Miller-Fisher syndrome (MFS) following C. jejuni infection.
18 s are the serological hallmark of the Miller Fisher syndrome (MFS) variant of the paralytic neuropath
19  triggering of the Guillain-Barre and Miller-Fisher syndrome neuropathies after C. jejuni infection.
20 he Guillain-Barre syndrome, including Miller-Fisher syndrome, subsets of immunoglobulin M paraprotein
21 with rheumatoid arthritis in whom the Miller Fisher syndrome variant of the Guillain-Barre syndrome d
22 ncluded in the analyses, and cases of Miller Fisher syndrome were excluded.
23  with chronic ataxic neuropathies and Miller Fisher syndrome were studied.
24 f the role of anti-GQ1b antibodies in Miller Fisher syndrome with particular respect to the motor ner
25 persons had Brighton level 1, 2, or 3 GBS or Fisher Syndrome, with symptom onset 1-119 days after vac

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。